Outcomes at 7 years post‐transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in<scp>BENEFIT</scp>and<scp>BENEFIT</scp>‐<scp>EXT</scp>Sander Florman, Christian P. Larsen, Valter Duro Garcı́a et al.|Clinical Transplantation|2018Cited by 9